In the light of previous literature reports, we suspect that low PCT values in patients with SARS-CoV-2 infection were due to the immunosuppressive therapy that was used concomitantly, which became at some point the standard of care in the case of COVID-19 patients [31]. This evidence concerns the gene CALCA and COVID-19.